Pfizer ordered to pay $103m over hormone drugs and breast cancer.
作者信息
Tanne Janice Hopkins
出版信息
BMJ. 2009 Nov 27;339:b5085. doi: 10.1136/bmj.b5085.
PMID:19946002
Abstract
摘要
相似文献
1
Pfizer ordered to pay $103m over hormone drugs and breast cancer.
BMJ. 2009 Nov 27;339:b5085. doi: 10.1136/bmj.b5085.
2
So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
J Natl Cancer Inst. 2007 Dec 19;99(24):1828-9, 1835. doi: 10.1093/jnci/djm285. Epub 2007 Dec 11.
3
Combination hormone therapy tied to slight increase in breast cancer deaths.
Mayo Clin Womens Healthsource. 2011 Mar;15(3):3.
4
Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.关于：近期绝经后妇女的雌激素加孕激素疗法与乳腺癌
Am J Epidemiol. 2009 Mar 15;169(6):784-5; author reply 785-6. doi: 10.1093/aje/kwn420. Epub 2009 Feb 10.
5
[Hormone replacement therapy in menopause].
Dtsch Med Wochenschr. 2003 Feb 21;128(8):400. doi: 10.1055/s-2003-37374.
6
Women seek alternatives to hormone replacement therapy.
Altern Ther Health Med. 2002 Sep-Oct;8(5):27.
7
The estrogen and progestin dilemma: new advice, labeling guidelines.
FDA Consum. 2003 Mar-Apr;37(2):10-1.
8
[Requiem for hormone replacement therapy? This does not apply to modern preparations!].
MMW Fortschr Med. 2003 Sep 11;145(37):13; author reply 13-4.
9
Hormone replacement therapy and breast cancer risk.激素替代疗法与乳腺癌风险。
J Fam Pract. 1995 Nov;41(5):501-2.
10
Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.经皮雌二醇-口服黄体酮与口服结合型马雌激素-醋酸甲羟孕酮对健康女性乳腺细胞增殖和 bcl-2 蛋白的影响。
Fertil Steril. 2011 Mar 1;95(3):1188-91. doi: 10.1016/j.fertnstert.2010.09.062. Epub 2010 Nov 10.
Zotero 插件